TCTR20211006004尚未招募2 期
Efficacy and safety of Thai recipes; Ha-rak, Juntaleela and Fatalaijone compare to Favipiravir in asymptomatic or mild COVID-19 patients
Giving Mind Nirvana Soul Foundation0 个研究点目标入组 400 人开始时间: 2021年10月6日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 Years 至 60 Years（—）
- 性别
- All
入选标准
- •1.20 (minimum) - 60 years of age
- •2.Diagnosis of COVID-19 infection confirmed by RT-PCR test for SAR-CoV-2
- •3.Asymptomatic or mild COVID-19 symptoms: fever, cough, malaise or headache
- •4.No uncontrollable underlying disease
- •5.Onset of symptoms is within 5 days or positive RT-PCR for SAR-CoV-2 within 5 days
- •6.Signed informed consent provided by patient
- •7.Willing to stay at research site at least 6 days
排除标准
- •1.COVID19 positive based on Antigen test but PCR negative
- •2.Severe or critical clinical conditions (Glasgow coma scale less than 14)
- •3.Severe COVID-19
- •4.Patient who is on mechanical ventilator
- •5.Abnormal chest x-ray
- •6.Dyspnea or respiratory rate above 30 per minute
- •7.Hypoxia or oxygen saturation less than 96 percent
- •8.Underlying diseases including Diabetes mellitus, uncontrollable hypertension
- •9.Abnormal liver function test: ALT/AST increased 5 times higher than the upper limit of normal or with Child Pugh C
- •10.Renal failure or Creatinine clearance (Cockcroft-Gault Equation) less than 30 ml/min or having hemodialysis/peritoneal dialysis
- •11.Known allergy or hypersensitivity to Thai recipes
- •12.Pregnant (female of childbearing age with positive urine pregnancy test) or Lactating female
研究者
相似试验
尚未招募
2 期
Efficacy and safety of Thai recipes; Ha-rak and Juntaleela compare to Favipiravir in asymptomatic or mild COVID-19 patientsconfirmed RT-PCR for SAR-CoV-2 patients with asymptomatic or mild symptomsAsymptomatic covid-19 patients, mild-symptom covid-19 patients, Ben-cha-lo-ka-wi-chian (Ha-rak), Juntaleela,Favipiravir, viral clearanceTCTR20211126004Giving Mind Nirvana Soul Foundation100
Unknown
1 期
Safety of Thai Traditional Medicine Recipes and Herbal Drink in Healthy VolunteersThere have been no scientific studies confirming toxicity. Therefore, to ensure that the dosage of Thai Traditional Medicine Recipes and Herbal Drink is safe and can be used for further research in Phase 2 in patients with COVID-19.COVID-19, Ha-rak, Ha-rak (Kun-So-Pit), Juntaleela, Fataliajorn-Prasa, Herbal drinkTCTR20211227002Giving Mind Nirvana Soul Foundation32
已完成
2 期
Integrative medicine for liver cancer patients with no definitive treatment: A pilot projectHepatocellular carcinoma is the major cancer problem in Thailand. The treatment for the advanced disease is still very limited. Targeted therapy is very expensive and cannot distributed to all patherbal recipethree rootshepatocellular carcinomaTCTR20180611001Thai Traditional Medical Knowledge Fund20
尚未招募
2 期
Efficacy and Safety of Thai Herbal Formularies Benja Amarit in Hepatocellular Carcinoma Patients: Clinical Trial Phase IIThis study to explore effficacy and safty of Thai herbal formularies Benja Amarit in hapatocellular carcinoma (Clinical trail phase II). Study in hepatocellular carcinoma patient,Child-Pugh score AHepatocellular carcinoma,Thai Herbal Formularies Benja Amarit,Thai herbalTCTR20170621002Department of Thai Traditional and Alternative Medicine81
Unknown
2 期
Thai recipes COVID-19mild to moderate COVID-19 patientsCOVID-19Thai recipiesMolnupiravirTCTR20220802009CRT100